EU Focus on Early Diagnosis and Cancer Treatment

European Week Against Cancer 2025

EU Focus on Early Diagnosis and Cancer Treatment

European Week Against Cancer 2025: EU-Funded Projects Making a Difference

 

Led by the Association of European Cancer Leagues (ECL), the European Week Against Cancer (25-31 May) highlights the importance of prevention, early detection, equitable access to treatment, and support for cancer patients. Despite advances in cancer therapy, disparities in screening, diagnosis, and treatment persist across EU member states.

 

Below are key EU-funded projects that are tackling these challenges and advancing high-quality care for all:

 

EU4Health Initiatives

 

i-Violin Project
This project introduced tools like the automatic CT image quality calculator, standardizing oncological imaging for chest, pelvis, and abdomen CT scans. i-Violin’s work has optimized imaging practices and emphasized collaboration among radiologists, radiographers, and medical physicists. A webinar series exploring its tools is now available online.

 

Joint Action (JA) CraNE
CraNE has laid the foundation for the European Network of Comprehensive Cancer Centres (CCCs), reducing inequalities in cancer care. By creating a Maturity Model and quality improvement pathways, CraNE supports future CCCs and Comprehensive Cancer Care Networks (CCCNs). The ongoing JA EUnetCCC is building on this progress.

 

JANE and JANE-2
The Joint Action JANE defined the scope for seven European Networks of Expertise (NoEs) in oncology, focusing on complex cancers, palliative care, survivorship, and more. JANE-2 is operationalizing these networks, fostering expert collaboration across Europe.

 

BEACON Project
BEACON mapped EU cancer centres’ capacities, consolidating data for patients, healthcare providers, and researchers. Its platform offers targeted insights to improve care delivery.

 

CAN.HEAL
This initiative integrated genomics into public health, advancing technologies like next-generation sequencing and molecular tumour profiling. CAN.HEAL developed tools like EU-wide Oncology Decision Support Tools (EU-oncDST) and liquid biopsy frameworks, promoting equitable cancer care.

 

Horizon 2020 Achievements

 

ProCAncer-I Project
Focusing on prostate cancer, ProCAncer-I uses AI to enhance diagnosis and treatment. Its platform has amassed MRI data from over 11,000 patients, ensuring AI tools meet fairness and accuracy standards.

 


Learn More

These projects exemplify Europe’s commitment to addressing cancer disparities and enhancing care quality. For further details, visit:

EUCanScreen supports these efforts by disseminating knowledge and fostering collaboration to improve cancer prevention and screening across Europe. Together, we can pave the way for equitable and effective cancer care for all.

 

👉 for more Info: https://hadea.ec.europa.eu/news/european-week-against-cancer-2025-eu-funded-projects-contributing-effective-diagnosis-and-treatment-2025-05-28_en

#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #HaDEA

🔗 Please don’t forget to Subscribe to EuCanScreen Newsletter! 💪

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen Vertical

 

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

email

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU tr

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Μετάβαση στο περιεχόμενο